SEC 13F Intelligence

Managers / Q2 2022 · view latest →

Gagnon Advisors, LLC

CIK 0001599466 · 1370 AVENUE OF THE AMERICAS, 26TH FLOOR, NEW YORK, NY, 10019 · 212-554-5050

Reported Value
$165M
Q2 2022
Positions
33
Filings on Record
32
2019–present window
Filed
Aug 1, 2022
original filing

Summary

Gagnon Advisors, LLC reported $165M in U.S.-listed holdings across 33 positions for Q2 2022.

Its largest position, PCRX, represents 8.3% of the portfolio.

The book was largely unchanged from Q1 2022.

Portfolio Metrics

Turnover
+2.3%
vs prior filed quarter
Top-10 Concentration
+56.2%
share of reported value
Largest Position
+8.3%
Pacira Biosciences

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $142MQ4 ’18Q1 ’19: $175MQ2 ’19: $175MQ3 ’19: $161MQ4 ’19: $178MQ4 ’19Q1 ’20: $107MQ2 ’20: $139MQ3 ’20: $163MQ4 ’20: $222MQ4 ’20Q1 ’21: $474MQ2 ’21: $263MQ3 ’21: $252MQ4 ’21: $252MQ4 ’21Q1 ’22: $217MQ2 ’22: $165MQ3 ’22: $154MQ4 ’22: $148MQ4 ’22Q1 ’23: $149MQ2 ’23: $149MQ3 ’23: $120MQ4 ’23: $114MQ4 ’23Q1 ’24: $115MQ2 ’24: $131MQ3 ’24: $155MQ4 ’24: $156MQ4 ’24Q1 ’25: $142MQ2 ’25: $149MQ3 ’25: $162MQ4 ’25: $158MQ4 ’25Q1 ’26: $136Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 72.9%Other: 15.3%MLP: 5.9%ETP: 2.8%REIT: 2.7%Other: 0.3%
  • Common Stock · 72.9% · $120M
  • Other · 15.3% · $25M
  • MLP · 5.9% · $10M
  • ETP · 2.8% · $5M
  • REIT · 2.7% · $5M
  • Other · 0.3% · $543,000

Quarter-over-Quarter Changes full breakdown →

vs Q1 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
YEXTYEXT INCADDED+812.5K1.62M+$2M$8M
BLFSBIOLIFE SOLUTIONS INCADDED+98.9K304.9K−$471,000$4M
07SSECUREWORKS CORPADDED+122.1K590.7K+$206,000$6M
EQIXEQUINIX INCTRIMMED−2.3K6.9K−$2M$5M
OPSEUROPSENS INCADDED+281.4K1.48M+$702,000$3M
ZUOUSDZUORA INCADDED+75.7K415.5K−$1M$4M
ALPHA AND OMEGA SEMICONDUCTOR LTDTRIMMED−47.9K177.6K−$6M$6M
PCRXPACIRA BIOSCIENCESTRIMMED−15.7K235.4K−$5M$14M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2022

30 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1PCRXPACIRA BIOSCIENCEShistory →COM8.31%$14M235.4K
2NAVIGATOR HOLDINGS LTDSHS7.05%$12M1.03M
3ALAIR LEASE CORPhistory →CL A6.02%$10M297.2K
4EPDENTERPRISE PRODS PARTNERS L Phistory →COM5.90%$10M399.9K
5EVAUSDENVIVA PARTNERS LPhistory →COM UNIT5.35%$9M154.3K
6BLBLACKLINE INChistory →COM5.00%$8M123.8K
7FIVNFIVE9 INChistory →COM4.93%$8M89.4K
8AMRCAMERESCO INChistory →CLA4.84%$8M175.3K
9YEXTYEXT INChistory →CL A4.70%$8M1.62M
10ETWOGBPE2OPEN PARENT HOLDINGS INCCOM CL A · W EXP 02/04/2024.24%$7M1.12M
11NEWREURNEW RELIC INChistory →COM4.15%$7M137.0K
1207SSECUREWORKS CORPhistory →CL A3.89%$6M590.7K
13CDNACAREDX INChistory →COM3.61%$6M277.3K
14ALPHA AND OMEGA SEMICONDUCTOR LTDSHS3.59%$6M177.6K
15HQ8FAPOLLO ENDOSURGERY INChistory →COM2.94%$5M1.33M
16DIREXION SHS ETF TR20YR TRES BEAR2.83%$5M46.1K
17EQIXEQUINIX INChistory →COM2.73%$5M6.9K
18BLFSBIOLIFE SOLUTIONS INChistory →COM NEW2.55%$4M304.9K
19LUMBER LIQUIDATORS HOLDINGS INCCOM2.33%$4M409.8K
20ZUOUSDZUORA INChistory →CL A2.25%$4M415.5K
21PRNPROFOUND MED CORPhistory →COM NEW1.95%$3M441.1K
22EVBGEUREVERBRIDGE INChistory →COM1.76%$3M104.4K
23OPSEUROPSENS INChistory →COM1.53%$3M1.48M
24SOMALOGIC INCCLASS A COM · W EXP 08/31/2021.45%$2M615.6K
25CNFINANCE HOLDINGS LIMITEDSPON ADS1.21%$2M784.7K
26SMFRUSDSEMA4 HOLDINGS CORPCOM CL A · W EXP 07/22/2021.18%$2M1.72M
27MIROMATRIX MED INCCOM1.11%$2M459.6K
28CELCCELCUITY INCCOM1.00%$2M181.4K
29FRSHFRESHWORKS INCCLASS A COM0.94%$2M118.6K
30PSIXPOWER SOLUTIONS INTERNATIONAL INCCOM0.66%$1M626.6K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$136M22Apr 22, 202613F-HRchanges · EDGAR ↗
Q4 2025$158M23Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$162M24Nov 3, 202513F-HRchanges · EDGAR ↗
Q2 2025$149M24Jul 23, 202513F-HRchanges · EDGAR ↗
Q1 2025$142M28May 12, 202513F-HRchanges · EDGAR ↗
Q4 2024$156M26Jan 24, 202513F-HRchanges · EDGAR ↗
Q3 2024$155M27Nov 12, 202413F-HRchanges · EDGAR ↗
Q2 2024$131M27Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$115M27May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$114M26Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$120M28Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$149M29Aug 8, 202313F-HRchanges · EDGAR ↗
Q1 2023$149M28Apr 10, 202313F-HRchanges · EDGAR ↗
Q4 2022$148M29Feb 7, 202313F-HRchanges · EDGAR ↗
Q3 2022$154M32Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$165M33Aug 1, 202213F-HRchanges · EDGAR ↗
Q1 2022$217M33May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$252M34Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$252M35Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$263M32Jul 28, 202113F-HRchanges · EDGAR ↗
Q1 2021$474M30May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$222M29Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$163M30Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020$139M26Aug 14, 2020RESTATEMENTchanges · EDGAR ↗
Q1 2020$107M27May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$178M32Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$161M32Nov 8, 201913F-HRchanges · EDGAR ↗
Q2 2019$175M33Aug 12, 201913F-HRchanges · EDGAR ↗
Q1 2019$175M33May 13, 201913F-HRchanges · EDGAR ↗
Q4 2018$142M31Jan 18, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.